MAPT and Alzheimer disease: Recently, a larger multi-center study from the Alzheimer’s Disease Neuroimaging Initiative cohort used targeted metabolomic profiling, and reported strong associations between bile acid profiles and Aβ, tau, and neurodegeneration biomarkers, which suggested that the gut-liver-brain axis may play a role in AD pathogenesis [1, 36].